Decreased fetal movements can indicate deterioration in the baby's condition, for example, because of chronic placental insufficiency. Clinical observations indicate that mothers commonly perceive an absence or reduction in the baby's movements for some days before a baby's death. For this reason, fetal movement monitoring is advised by caregivers and is used spontaneously by mothers to assess the baby's well-being. Women's perception of decreased fetal movement is decreased with cigarette smoking, maternal obesity and if the placenta is at the front of the womb. Management strategies in response to perceived decreased fetal movements include early delivery, expectant management with close surveillance of the baby, cardiotocography (visual or analysed by computer to follow the baby’s heart beat with uterine activity), ultrasound examination including Doppler ultrasound, and fetal arousal tests (either cardiotocographic or clinical observation where electronic fetal assessment methods are not available) to assess the baby’s well-being. Evidence on the effectiveness of monitoring fetal movements and the subsequent management strategies in improving outcomes is limited. Given the high rate of false positive results for both fetal movement assessment and follow-up tests, there is a real possibility of risks with unnecessary interventions or the baby being born premature and increased anxiety for the mother.
Thirteen studies met the inclusion criteria. This review found that very little is known from high-quality randomised clinical trials to guide the management of reported decreased fetal movements. No randomised trials of management of decreased fetal movement alone were found. However, other systematic reviews indicate that Doppler ultrasound, computerised cardiotocography, and fetal arousal to facilitate cardiotocography show promise in high-risk pregnancies.
閱讀完整摘要
Clinical observations indicate that mothers commonly perceive a reduction in, or absence of, the baby's movements for some days preceding a baby's death. For this reason, fetal movement monitoring is advised by caregivers and used spontaneously by mothers to assess the baby's well-being. However, it is possible that the harmful effects of interventions may outweigh the benefits of such testing. Evidence of effectiveness of fetal movement screening to improve outcomes is limited, though indirect evidence suggests a potential benefit. A secondary question is whether any specific management response to perceived decreased fetal movements (DFM) improves clinical outcome.
目的
To determine, from the best available evidence, the effectiveness of various management strategies for DFM.
搜尋策略
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (28 February 2012) and bibliographies of included studies.
選擇標準
Randomised clinical trials comparing various management strategies for DFM, including delivery, expectant management, cardiotocography (visual and computerised), ultrasound examination including Doppler ultrasound, and fetal arousal tests (cardiotocographic or clinical).
資料收集與分析
Two assessors evaluated potentially eligible trials for inclusion, and extracted data onto a purpose-designed form. Where DFM was one among a number of inclusion criteria for the trial, we contacted trial authors for information on outcomes specific to the DFM subgroups.
主要結果
No randomised trials of management of DFM were found. Of 13 randomised trials of management strategies for pregnancies with risk factors for fetal compromise including DFM, data on the DFM subgroups could only be provided by the authors of one trial. The numbers were too small for meaningful analysis (there were 28 cases of DFM).
作者結論
There are insufficient data from randomised trials to guide practice regarding the management of DFM. Based on the results of other systematic reviews of management strategies for women whose babies are thought to be at risk of compromise for various reasons, the following strategies show promise and may be prioritised for further research: Doppler ultrasound studies, computerised cardiotocography, and fetal arousal to facilitate cardiotocography.
For settings where electronic fetal assessment methods are not available, clinical fetal arousal tests should be investigated.
